Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
Open Access
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 53 (4) , 784-791
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart DiseaseCirculation, 2011
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein PhenotypeCirculation, 2010
- HDL in humans with cardiovascular disease exhibits a proteomic signatureClinica Chimica Acta, 2010
- Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small ApolipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent CardioprotectionScience, 2008
- Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic MiceCirculation, 2008
- Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both gendersAtherosclerosis, 2003
- LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and EArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.Journal of Clinical Investigation, 1985